Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed August 04, 2017]

As part of its series of white papers tracking clinical trials activity across the world, GlobalData recently compiled a summary of the clinical trials initiated in Japan. The company captured records of 8,615 clinical trials across all diseases and phases that had a start date between 1 January, 2012, and 31 December, 2016.

Out of the ten largest industry and non-industry sponsors of Japanese clinical trials, eight were pharmaceutical companies and two were government or academic institutions. Novartis was the sponsor with the largest number of clinical trials, followed by Keio University. The rest were GlaxoSmithKline, Takeda, Bayer, Osaka University, Astellas, AstraZeneca,  Eli Lilly, and Daiichi Sankyo.

GlobalData also analysed the specific major industry sponsors that initiated trials in Japan between 2012 and 2016. Novartis held first place, followed by GlaxoSmithKline. The remaining industry sponsors were Takeda, Bayer, Astellas, AstraZeneca, Eli Lilly, Daiichi Sankyo, Merck, and Pfizer, as shown in Figure 1.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.